Research ArticleArticle
Treatment with Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Comparison Between Private Rheumatology Practices and Academic Centers in a Large Observational Cohort
Adrian Ciurea, Ulrich Weber, Daniel Stekhoven, Almut Scherer, Giorgio Tamborrini, Jürg Bernhard, Martin Toniolo, Peter M. Villiger, Pascal Zufferey, Rudolf O. Kissling, Beat A. Michel and Pascale Exer on behalf of the Rheumatologists of Swiss Clinical Quality Management
The Journal of Rheumatology November 2014, jrheum.140229; DOI: https://doi.org/10.3899/jrheum.140229
Adrian Ciurea
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Ulrich Weber
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Daniel Stekhoven
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Almut Scherer
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Giorgio Tamborrini
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Jürg Bernhard
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Martin Toniolo
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Peter M. Villiger
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Pascal Zufferey
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Rudolf O. Kissling
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Beat A. Michel
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Pascale Exer
From the Department of Rheumatology, University Hospital; Department of Rheumatology, Uniklinik Balgrist; Swiss Clinical Quality Management Foundation, Zurich; Department of Rheumatology, Bethesda Hospital, Basel; Department of Rheumatology and Rehabilitation, Bürgerspital, Solothurn; Department of Rheumatology and Clinical Immunology, University Hospital, Bern; Department of Rheumatology, Centre Hospitalier Universitaire Vaudois, Lausanne; Praxis Rheuma-Basel, Basel, Switzerland. Supported in part by a grant from the Swiss Ankylosing Spondylitis Foundation and by an unrestricted educational grant from Merck Sharp & Dohme in collaboration with Swiss Clinical Quality Management (SCQM). The SCQM Foundation was financially supported by the Swiss Society of Rheumatology, the Balgrist Foundation, the ARCO Foundation, and by Abbott, Bristol-Myers-Squibb, Merck Sharp & Dohme, Pfizer, Roche, and UCB. Dr. Ciurea has received consulting and/or speaking fees from Abbvie, Merck Sharp & Dohme, Pfizer, and UCB. Dr. Weber has received honoraria from Abbvie for being a workshop convenor of the International Course on Magnetic Resonance Imaging in Spondyloarthritis and for contributing to a slide kit on SpA. Dr. Exer has received speaking fees from Abbvie. A. Ciurea, MD; M. Toniolo, MD; B.A. Michel, MD, Department of Rheumatology, University Hospital Zurich; U. Weber, MD, King Christian 10th Hospital for Rheumatic Diseases, Gråsten, Denmark; R.O. Kissling, MD, Uniklinik Balgrist; D. Stekhoven, PhD; A. Scherer, PhD, SCQM Foundation; G. Tamborrini, MD, Bethesda Hospital; J. Bernhard, Department of Rheumatology and Rehabilitation, Bürgerspital Solothurn; P.M. Villiger, MD, Department of Rheumatology and Clinical Immunology, University Hospital Bern; P. Zufferey, MD, Department of Rheumatology, Centre Hospitalier Universitaire Vaudois; P. Exer, MD, Praxis Rheuma-Basel. Address correspondence to Dr. A. Ciurea, Department of Rheumatology, University Hospital Zurich, Gloriastrasse 25, CH-8091 Zurich, Switzerland. E-mail: adrian.ciurea@usz.ch. Accepted for publication September 17, 2014.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Treatment with Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Comparison Between Private Rheumatology Practices and Academic Centers in a Large Observational Cohort
Adrian Ciurea, Ulrich Weber, Daniel Stekhoven, Almut Scherer, Giorgio Tamborrini, Jürg Bernhard, Martin Toniolo, Peter M. Villiger, Pascal Zufferey, Rudolf O. Kissling, Beat A. Michel, Pascale Exer
The Journal of Rheumatology Nov 2014, jrheum.140229; DOI: 10.3899/jrheum.140229
Treatment with Tumor Necrosis Factor Inhibitors in Axial Spondyloarthritis: Comparison Between Private Rheumatology Practices and Academic Centers in a Large Observational Cohort
Adrian Ciurea, Ulrich Weber, Daniel Stekhoven, Almut Scherer, Giorgio Tamborrini, Jürg Bernhard, Martin Toniolo, Peter M. Villiger, Pascal Zufferey, Rudolf O. Kissling, Beat A. Michel, Pascale Exer
The Journal of Rheumatology Nov 2014, jrheum.140229; DOI: 10.3899/jrheum.140229